Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.87746 | 82 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.74223 | 80 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.74255 | 81 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.51425 | 85 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.13429 | 83 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.52225 | 80 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.7446 | 82 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.70776 | 81 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.67161 | 80 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.83625 | 81 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.65991 | 80 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.75447 | 80 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.72508 | 81 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.70493 | 81 |